# Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study

> **NCT06771791** · PHASE3 · RECRUITING · sponsor: **University Hospital, Strasbourg, France** · enrollment: 110 (estimated)

## Conditions studied

- Allergies

## Interventions

- **OTHER:** oral provocation test

## Key facts

- **NCT ID:** NCT06771791
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-08
- **Primary completion:** 2027-05-05
- **Final completion:** 2027-05-05
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06771791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06771791, "Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06771791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*